Publications by authors named "Pascal Wielders"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

234

Total Likes

498

Extended Reach

3,074,357

Social Features

165
I
Identifying phenotypes in OSA patients with an indication for CPAP treatment using clinical data and experienced symptom severity.
Marion Teunissen, Pascal Wielders, Catherine Bolman

J Patient Rep Outcomes· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elderly patients with tuberculosis in a low-incidence country - Clinical characteristics, inflammation and outcome.
Cynthia van Arkel, Iris Storms, Lisa Kurver, Frank Smeenk, Pascal Wielders

J Infect· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial.
Christian Friedrich, Klaus Francke, Surinder S Birring, Jan Willem K van den Berg, Paul A Marsden, Pascal Wielders

Respir Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-1 receptor antagonist anakinra as treatment for paradoxical responses in HIV-negative tuberculosis patients: A case series.
Cynthia van Arkel, Martin Boeree, Cécile Magis-Escurra, Wouter Hoefsloot, Neeltje Carpaij, Pascal Wielders

Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of once-daily fluticasone furoate/vilanterol vilanterol alone on bone mineral density in patients with COPD: a randomized, controlled trial.
Francois Maltais, Isabelle Schenkenberger, Pascal L M L Wielders, Juan Ortiz de Saracho, Kenneth Chinsky

Ther Adv Respir Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical Error Frequency and the Impact of Training with Inhalers Commonly used for Maintenance Treatment in Chronic Obstructive Pulmonary Disease.
David J Collier, Pascal Wielders, Job van der Palen, Logan Heyes, Dawn Midwinter

Int J Chron Obstruct Pulmon Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying a nasal gene expression signature associated with hyperinflation and treatment response in severe COPD.
Alen Faiz, Kai Imkamp, Erica van der Wiel, Ilse M Boudewijn, Gerard H Koppelman, Pascal Wielders

Sci Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERS Congress highlight: educational forum on continuing professional development.
Carolin Sehlbach, Amy Farr, Martin Allen, Joaquim Gea Guiral, Pascal L M L Wielders

Breathe (Sheff)· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nasal gene expression differentiates COPD from controls and overlaps bronchial gene expression.
Ilse M Boudewijn, Alen Faiz, Katrina Steiling, Erica van der Wiel, Eef D Telenga, Pascal Wielders

Respir Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial.
Claire L Ambery, Pascal Wielders, Andrea Ludwig-Sengpiel, Robert Chan, John H Riley

Drugs R D· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new class of bronchodilator improves lung function in COPD: a trial with GSK961081.
Pascal L M L Wielders, Andrea Ludwig-Sengpiel, Nicholas Locantore, Suus Baggen, Robert Chan

Eur Respir J· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of an oral MMP-9 and -12 inhibitor, AZD1236, on biomarkers in moderate/severe COPD: a randomised controlled trial.
Ronald Dahl, Ingrid Titlestad, Ari Lindqvist, Pascal Wielders, Heather Wray

Pulm Pharmacol Ther· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of formoterol Turbuhaler in the emergency treatment of patients with obstructive airway diseases.
Kristien M van den Broek, Pascal L M L Wielders, Jacques P H M Creemers, Frank W J M Smeenk

Respir Med· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased systemic inflammation is a risk factor for COPD exacerbations.
Karin H Groenewegen, Dirkje S Postma, Wim C J Hop, Pascal L M L Wielders, Noel J J Schlösser

Chest· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical mediastinal staging in daily practice.
Sietske A Smulders, Frank W J M Smeenk, Maryska L G Janssen-Heijnen, Pascal L M L Wielders, Dirk R A J de Munck

Lung Cancer· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis